News

Article

BioPharm International Sponsored eBooks

BioPharm International Sponsored eBooks-09-17-2024
Volume

Emerging Therapies 2024

Articles in this issue
Emerging Therapies 2024

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey
How the 15% US-EU Tariff Cap Affects Bio/pharma
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
small interfering RNA bound to a messenger RNA, cartoon model with semi-transparent surface. siRNAs are synthetic RNA interference tools used for inducing temporary reduction of mRNA expression. | Image Credit: © petarg - © petarg - stock.adobe.com
August 26th 2025

Hongene Expands exNA Technology Access for RNA Therapeutics Research with New Licensing Deal

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 26th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Silver Spring, MD, USA - June 25, 2022: Closeup of the FDA sign seen at its headquarters campus in Silver Spring, Maryland. FDA is a federal agency of the Department of Health and Human Services | Image Credit: © Tada Images - stock.adobe.com
August 26th 2025

Novo Receives FDA 483 for Acquired Catalent Site

Christopher Cole
Mastering Antibody-Drug Conjugates
August 26th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
PRAGUE, CZECHIA - NOVEMBER 1, 2019: Astellas logo in front of their main office for Prague. Astellas Pharma is a Japanese Pharmaceutical company spread worldwide | Image Credit: © Jerome - stock.adobe.com
August 26th 2025

Astellas and Pfizer Bladder Cancer Therapy Recommended by UK’s NICE

Patrick Lavery
Human urinary system kidneys with bladder anatomy on doctor hands. Treatment of urinary tract infections, urinary incontinence or urinary retention. Urology concept. | Image Credit: © Orawan - stock.adobe.com
August 26th 2025

Iterum Launches UTI Drug, First Oral Penem Antibiotic Commercially Available in US

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.